NovoCure Ltd (NVCR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 250M 500M 750M Q3 '21: 545.8M Q4 '21: 535M Q1 '22: 537.9M Q2 '22: 545.2M Q3 '22: 542.6M Q4 '22: 537.8M Q1 '23: 522.5M Q2 '23: 507.7M Q3 '23: 504M Q4 '23: 509.3M Q1 '24: 525.7M Q2 '24: 550M Q3 '24: 577.7M Q4 '24: 605.2M Q1 '25: 621.7M Q2 '25: 630.2M Q3 '25: 642.3M Q4 '25: 655.4M Q1 '26: 674.4M Q2 '26: 699.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 200M 400M 600M Q3 '21: 432.4M Q4 '21: 420.2M Q1 '22: 421.7M Q2 '22: 429.1M Q3 '22: 427M Q4 '22: 423M Q1 '23: 405.7M Q2 '23: 385.4M Q3 '23: 379.4M Q4 '23: 381.1M Q1 '24: 393.3M Q2 '24: 417M Q3 '24: 441.5M Q4 '24: 468M Q1 '25: 479.7M Q2 '25: 481.3M Q3 '25: 484.1M Q4 '25: 488.5M Q1 '26: 507.1M Q2 '26: 532.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-240M -160M -80M 0 80M 160M 240M Q3 '21: -8.8M Q4 '21: -44.3M Q1 '22: -45.1M Q2 '22: -53.9M Q3 '22: -69.9M Q4 '22: -89.5M Q1 '23: -149M Q2 '23: -190.5M Q3 '23: -224.1M Q4 '23: -232.9M Q1 '24: -214.1M Q2 '24: -185.1M Q3 '24: -158.9M Q4 '24: -170.5M Q1 '25: -166.8M Q2 '25: -172.8M Q3 '25: -176.7M Q4 '25: -153.8M Q1 '26: -183.4M Q2 '26: -154.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-240M -160M -80M 0 80M 160M 240M Q3 '21: -27M Q4 '21: -58.4M Q1 '22: -58.9M Q2 '22: -68.2M Q3 '22: -81.7M Q4 '22: -92.5M Q1 '23: -140.9M Q2 '23: -174.4M Q3 '23: -197.3M Q4 '23: -207M Q1 '24: -192.7M Q2 '24: -168.7M Q3 '24: -149.8M Q4 '24: -168.6M Q1 '25: -164.2M Q2 '25: -170.9M Q3 '25: -177.7M Q4 '25: -136.2M Q1 '26: -173M Q2 '26: -148.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 60M 120M 180M Q3 '21: 113.3M Q4 '21: 114.9M Q1 '22: 116.2M Q2 '22: 116.1M Q3 '22: 115.7M Q4 '22: 114.9M Q1 '23: 116.8M Q2 '23: 122.3M Q3 '23: 124.6M Q4 '23: 128.3M Q1 '24: 132.4M Q2 '24: 133M Q3 '24: 136.3M Q4 '24: 137.2M Q1 '25: 142M Q2 '25: 148.8M Q3 '25: 158.2M Q4 '25: 166.9M Q1 '26: 167.3M Q2 '26: 166.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-100M -50M 0 50M 100M 150M Q3 '21: 121.8M Q4 '21: 82.8M Q1 '22: 61.3M Q2 '22: 50.9M Q3 '22: 48.9M Q4 '22: 30.8M Q1 '23: 17.7M Q2 '23: -20.8M Q3 '23: -62.5M Q4 '23: -73.3M Q1 '24: -88.2M Q2 '24: -67.2M Q3 '24: -37.5M Q4 '24: -26.4M Q1 '25: -30.5M Q2 '25: -44.7M Q3 '25: -34.5M Q4 '25: -49M Q1 '26: -26.9M Q2 '26: -2.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-150M -100M -50M 0 50M 100M 150M Q3 '21: 106.2M Q4 '21: 58.6M Q1 '22: 36M Q2 '22: 24.1M Q3 '22: 19.7M Q4 '22: 9.4M Q1 '23: -4.6M Q2 '23: -45.9M Q3 '23: -89.2M Q4 '23: -100.4M Q1 '24: -121M Q2 '24: -104.5M Q3 '24: -78.2M Q4 '24: -69.2M Q1 '25: -72.1M Q2 '25: -80.4M Q3 '25: -65.2M Q4 '25: -75.7M Q1 '26: -48.1M Q2 '26: -25.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q4 '20: 110.6M Q1 '21: 102.6M Q2 '21: 103.5M Q3 '21: 103.7M Q4 '21: 103.9M Q1 '22: 104.2M Q2 '22: 104.6M Q3 '22: 104.9M Q4 '22: 105M Q1 '23: 105.7M Q2 '23: 106.3M Q3 '23: 106.8M Q1 '24: 107.3M Q2 '24: 107.7M Q3 '24: 108.2M Q1 '25: 110.3M Q2 '25: 111.6M Q3 '25: 111.9M Q1 '26: 114.1M Q2 '26: 116M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.10 -1.40 -0.70 0.00 0.70 1.40 2.10 Q3 '21: -0.27 Q4 '21: -0.56 Q1 '22: -0.56 Q2 '22: -0.65 Q3 '22: -0.77 Q4 '22: -0.88 Q1 '23: -1.34 Q2 '23: -1.65 Q3 '23: -1.86 Q4 '23: -1.94 Q1 '24: -1.80 Q2 '24: -1.57 Q3 '24: -1.39 Q4 '24: -1.56 Q1 '25: -1.51 Q2 '25: -1.56 Q3 '25: -1.61 Q4 '25: -1.22 Q1 '26: -1.53 Q2 '26: -1.30 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.